THRN earnings

Record Net Sales With Growth of 33.1%; Raises Full-Year Guidance Midpoints for Net Sales and Gross Margin NEW YORK, Aug. 8, 2023  /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the second quarter ended June 30, 2023. Second Quarter Highlights: Net sales grew 33.1% year-over-year to $72.7 million, with direct-to-consumer ("DTC") sales growth of 39.3%Gross profit grew 35.7% year-over-year to $40.6 million; gross profit as a % of net sales increased year-over-year to 55.9%.Net incom

Company Withdraws Participation in the Canaccord Genuity 43rd Annual Growth Conference on Aug. 10 NEW YORK, Aug. 1, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its second quarter 2023 financial results after market close on Tuesday, Aug. 8, 2023. The company will host a conference call to discuss its results on Tuesday, Aug. 8, 2023, at 5:00 p.m. (U.S. Eastern Time). A live webcast and replay of the call will be available on the investors section of the

Net Sales Growth of 20.7%; Reaffirms Full-Year 2023 Guidance NEW YORK, May 11, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the first quarter ended March 31, 2023. First Quarter Highlights: Net sales grew 20.7% year-over-year to $65.2 million, with direct-to-consumer ("DTC") sales growth of 41.0%Gross profit grew 16.3% year-over-year to $34.3 million; gross p

NEW YORK, May 1, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its first quarter 2023 financial results after market close on Thurs, May 11, 2023. The company will host a conference call to discuss its results on Thurs, May 11, 2023, at 5:30 p.m. (U.S. Eastern Time). A live webcast and replay of the call will be available on the investors section of the company's website at https://investors.thornehealthtech.com. The conference call can also be accessed b

Net Sales Growth of 24.1% and Adj. EBITDA1 growth of 19.1% for Full-Year 2022; Provides Full-Year 2023 Guidance NEW YORK, March 30, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, today announced its financial results for the fourth quarter and full-year ended December 31, 2022. Fourth Quarter 2022 Highlights: Net sales grew 27.7% year-over-year to $63.0 million, with direct-to-consumer ("DTC") sales growth of 46.1%Gross p

NEW YORK, March 29, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its fourth quarter and full-year 2022 financial results after market close on Thurs, Mar. 30, 2023. The company will host a conference call to discuss its results on Fri, Mar. 31, 2023, at 8 a.m. (U.S. Eastern Time). A live webcast and replay of the call will be available on the investors section of the company's website at https://investors.thornehealthtech.com.   The conference call can a

Updates Full-Year 2022 Guidance NEW YORK, Nov. 9, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in developing personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the third quarter ended September 30, 2022. Third Quarter Highlights: Net sales grew 21.7% year-over-year to $58.4 million, with direct-to-consumer ("DTC") sales growth of 47.2%Gross profit grew 10.3% year-over-year to $28.2 million; gross margin decreased 500 basis

NEW YORK, Oct. 18, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellness, will release its third quarter 2022 financial results after market close on Wednesday, Nov. 09, 2022. The company will host a conference call to discuss its results on Thursday, Nov. 10, 2022, at 8 a.m. (U.S. Eastern Time). A live webcast and replay of the call will be available on the investors section of the company's website at https://investors.thornehealthtech.com. The conference call can also be ac

Revises Full-Year 2022 Guidance NEW YORK, Aug. 9, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in developing personalized, innovative solutions to help people live healthier, longer lives, today announced its financial results for the second quarter ended June 30, 2022. Second Quarter Highlights: Net sales grew 30.7% year-over-year to $56.1 million, with direct-to-consumer (DTC) sales growth of 69.6%Gross profit grew 37.0% year-over-year to $31.4 million; gross margin increased 260 basis points year over

NEW YORK, July 19, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellness, will release its second quarter 2022 financial results after the market close on Tuesday. Aug. 09, 2022. The company will host a conference call on Wednesday, Aug. 10, 2022, at 8 a.m. (U.S. Eastern Time) to discuss its second quarter 2022 financial results. A live webcast of the call can be accessed by logging onto the investors section of the Thorne HealthTech website at https://investors.thornehealthtech.com. A replay will be available on the same website after the call.

Reaffirms Full-Year 2022 Guidance NEW YORK, May 11, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech" or the "Company") (NASDAQ: THRN), a leader in developing personalized, innovative solutions to help people live healthier, longer lives, today announced its financial results for the first quarter ended March 31, 2022. Highlights: Net sales grew 22.9% to $54.7 million, with direct-to-consumer ("DTC") sales growth of 33.0%Gross profit grew 29.6% to $30.1 million; gross margin increased 285 basis points to 55.1%Net income attributable to common stockholders of $5

NEW YORK, Feb. 25, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, will host a conference call on Tuesday, March 15, 2022, at 8 a.m. (U.S. Eastern Time) to discuss its fourth quarter and full-year 2021 financial results. A live webcast of the call can be accessed by logging onto the investors section of the Thorne HealthTech website at https://investors.thornehealthtech.com. A replay will be available on the same website after the call. In addition, the conference call

NEW YORK, Oct. 25, 2021 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, will release third quarter 2021 financial results on Wednesday, November 10, 2021, prior to the market open. In conjunction with the earnings release, Thorne HealthTech's management team will host a conference call at 8:30 a.m. ET. To listen to the conference call on your telephone, please dial 646-904-5544 for U.S. callers, or +1-929-526-1599 for international callers, approximately ten minutes prior